Combination of pegylated liposomal doxorubicin plus gemcitabine in heavily pretreated metastatic breast cancer patients: Long-term results from a single institution experience-Reference-Cited by-同舟云学术

Combination of pegylated liposomal doxorubicin plus gemcitabine in heavily pretreated metastatic breast cancer patients: Long-term results from a single institution experience

Published:2017-12-29 Issue:4 Volume:24 Page:473-479
ISSN:1075-122X
Container-title:The Breast Journal
language:en
Short-container-title:Breast J

Author:

Martin-Romano Patricia¹,Baraibar Iosune¹,Espinós Jaime¹,Legaspi Jairo¹,López-Picazo Jose M.¹,Aramendía Jose Manuel¹,Fernández Oscar A.¹,Santisteban Marta¹^ORCID

Affiliation:

1. Department of Medical Oncology. Clínica; Universidad de Navarra; Pamplona, Navarra Spain

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tbj.12975/fullpdf

Reference26 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Cardoso;Ann Oncol,2012

3. Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: Analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group;Mouridsen;J Clin Oncol,2003

4. Results of the CONFIRM phase III trial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor-positive advanced breast cancer;Leo;J Clin Oncol,2010

5. Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: Overall survival results from BOLERO-2dagger;Piccart;J Clin Oncol,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on Classic and Novel Approaches in Metastatic Triple-Negative Breast Cancer Treatment: A Comprehensive Review;Biomedicines;2023-06-20

2. Pegylated liposomal doxorubicin (Duomeisu®) monotherapy in patients with HER2-negative metastatic breast cancer heavily pretreated with anthracycline and taxanes: a single-arm, phase II study;Breast Cancer Research and Treatment;2023-03-06

3. Current status of nanomedicine for breast cancer treatment;Targeted Nanomedicine for Breast Cancer Therapy;2022

4. Targeting Engineered Nanoparticles for Breast Cancer Therapy;Pharmaceutics;2021-11-01

5. How to conduct integrated pharmaceutical care for patients with hand-foot syndrome associated with chemotherapeutic agents and targeted drugs;Journal of Oncology Pharmacy Practice;2021-04-19